Abstract Although virus–host interactions are usually studied in a single cell type using in vitro assays in immortalized cell lines or isolated cell populations, it is important to remember that what is happening inside one infected cell does not translate to understanding how an infected cell behaves in a tissue, organ or whole organism. Infections […]
New York, July 24, 2023 (GLOBE NEWSWIRE) — The global microtainer blood collection market stood at US$ 1.1 billion in 2022 and is forecasted to expand at a CAGR of 6.6% from 2023 to 2033. Microtainers allow for a minimally intrusive blood collection process that is increasingly being preferred by healthcare professionals. Increased need for […]
The American Legion Jul 24, 2023 Jul 24, 2023 The American Legion will host a Red Cross blood drive during the 104th National Convention in Charlotte, N.C. The drive will be conducted on Friday, Aug. 25, and Monday, Aug. 28, from 9 a.m. to 3 p.m. each day, in Hall B of the Charlotte Convention […]
Pictured: Corporate headquarters of Gilead in Silicon Valley/iStock, Sundry Photography Gilead has discontinued the Phase III ENHANCE study of its investigational anti-CD47 antibody magrolimab for the treatment of patients with higher-risk myelodysplastic syndromes, the company announced Friday. The decision to end the study was triggered by a planned analysis of its data, which satisfied the […]
Researchers say the central districts in Sydney are close to becoming the first place in the world to reach the U.N.’s target for ending transmission of HIV. The city was once at the heart of Australia’s HIV epidemic but new infections among gay men have fallen by 88% between 2010 and 2022. The U.N.’s goal […]
Virginians may indicate their blood type when they renew or replace their driver’s license or ID at dmv.virginia.gov or in-person at any Virginia Department of Motor Vehicles (DMV) customer service center, according to the DMV. “The law was intended to aid individuals and first responders when every second counts in an emergency,” said DMV Commissioner […]
Partnership combines Roche’s proven track record of successfully developing and launching innovative medicines worldwide with Alnylam’s leadership in RNAi therapeutics Zilebesiran, a Phase 2 RNAi therapeutic, has best-in-disease potential for patients with hypertension at high risk of cardiovascular morbidity and mortality, by robustly and durably lowering blood pressure Hypertension, the leading cause of cardiovascular disease, […]
(CNN) — Scientists have long known that people living with HIV face a higher risk of heart disease. The statin drug pitavastatin, however, might offer a solution. In a phase 3 clinical trial, individuals with an HIV infection who took pitavastatin – a medication used to lower high cholesterol – were 35% less likely to […]
Primary prevention study enrolled people with HIV who would not normally be prescribed a statin A widely used statin medication reduced the risk of heart attacks, strokes and other cardiovascular events when given to people with HIV who are at low to moderate risk for cardiovascular disease (CVD), according to results from the REPRIEVE study […]
A statin a day reduces the risk of heart disease in younger people living with HIV, according to a new study published Sunday in the New England Journal of Medicine. “What the study is saying is if you add a statin treatment to antiretroviral therapy … that will now prevent to a large degree, the […]